NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Study on the Detection of Pleuropulmonary Manifestations in Rheumatoid Arthritis
Study on the Detection of Pleuropulmonary Manifestations in Rheumatoid Arthritis
RecruitingN/A
Sponsor: Medical University Innsbruck
Conditions: Rheumatic Arthritis, Interstitial Lung Disease in Patients With Rheumatoid Arthritis
Countries: Austria
The aim of the study is to develop a standardized, risk-adapted screening protocol for detecting pleuropulmonary manifestations in patients with rheumatoid arthritis. To assess the risk of these manifestations, a comprehensive range of functional and clinical evaluations will be performed and correlated with structural lung assessments using computed tomography (CT).
Eligibility overview
Sex: ALL
Age: 18 Years to —
Healthy volunteers: No
Study type: OBSERVATIONAL
Eligibility criteria
Inclusion Criteria: * Patients ≥18 years diagnosed with rheumatoid arthritis according to current ACR/EULAR criteria * Residence in Austria * Signed and dated consent of the patient in accordance with ICH-GCP guidelines Exclusion Criteria: * pregnancy * age below 18 years * Contraindications to study-related routine examinations (e.g., inability to draw blood due to needle phobia, no CT scan possible due to claustrophobia, pregnancy, etc.)
Locations (1)
- Innsbruck, Austria, Austria